MLLT3 and leukemia: Analysis on days 15 and 28 post-injection identified fewer GFP+ cells in mice injected with GFP-MLL-AF9 Rnf5−/− cells than in mice injected with GFP-MLL-AF9 Rnf5WT cells, indicating a delay in leukemia development (Fig. 4g).